Literature DB >> 23688322

Inhibiting interleukin-4 and interleukin-13 in difficult-to-control asthma.

Michael E Wechsler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23688322     DOI： 10.1056/NEJMe1305426

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13.

Authors:  Corrado Pelaia; Giulia Pelaia; Claudia Crimi; Angelantonio Maglio; Giuseppe Armentaro; Cecilia Calabrese; Angela Sciacqua; Luca Gallelli; Alessandro Vatrella
Journal:  Vaccines (Basel)       Date:  2022-06-19

2.  Advances in pediatric asthma in 2013: coordinating asthma care.

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2014-03       Impact factor: 10.793

3.  A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair.

Authors:  D Karo-Atar; A Bordowitz; O Wand; M Pasmanik-Chor; I E Fernandez; M Itan; R Frenkel; D R Herbert; F D Finkelman; O Eickelberg; A Munitz
Journal:  Mucosal Immunol       Date:  2015-07-08       Impact factor: 7.313

Review 4.  Unmet needs in respiratory diseases : "You can't know where you are going until you know where you have been"--Anonymous.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 5.  Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review.

Authors:  Kiran Kumar Rathinam; Justin Jacob Abraham; Thangavel Mahalingam Vijayakumar
Journal:  Curr Ther Res Clin Exp       Date:  2019-10-28

Review 6.  Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets.

Authors:  Corrado Pelaia; Enrico Heffler; Claudia Crimi; Angelantonio Maglio; Alessandro Vatrella; Girolamo Pelaia; Giorgio Walter Canonica
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

Review 7.  Dupilumab: a novel treatment for asthma.

Authors:  Alessandro Vatrella; Immacolata Fabozzi; Cecilia Calabrese; Rosario Maselli; Girolamo Pelaia
Journal:  J Asthma Allergy       Date:  2014-09-04

Review 8.  Genetic Mechanisms of Asthma and the Implications for Drug Repositioning.

Authors:  Yue Huo; Hong-Yu Zhang
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

9.  Therapeutic and prophylactic deletion of IL-4Ra-signaling ameliorates established ovalbumin induced allergic asthma.

Authors:  Jermaine Khumalo; Frank Kirstein; Martyna Scibiorek; Sabelo Hadebe; Frank Brombacher
Journal:  Allergy       Date:  2020-01-30       Impact factor: 13.146
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.